A phase ib study of pembrolizumab following trans-arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): Petal

Category Primary study
JournalHepatology v70 suppl.1 2019
Year 2019
This article has no abstract
Epistemonikos ID: 611e5e2994468512535b17db4e4442ae45957d13
First added on: Feb 11, 2025